Does acarbose reduce the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance?
Patients with impaired glucose tolerance (IGT)
Acarbose
Risk of cardiovascular disease and hypertension
Acarbose treatment may be associated with a reduced risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance.
This study suggests that treating IGT patients with acarbose is associated with a significant reduction in the risk of cardiovascular disease and hypertension.
Building similarity graph...
Analyzing shared references across papers
Loading...
Jean‐Louis Chiasson
Western University
Robert G. Josse
University of Toronto
Ramón Gomis
Universitat Oberta de Catalunya
JAMA
Université de Montréal
Centre Hospitalier de l’Université de Montréal
Hôtel-Dieu de Montréal
Building similarity graph...
Analyzing shared references across papers
Loading...
Chiasson et al. (Tue,) studied this question.
synapsesocial.com/papers/69db573b0d8d6ef495a3d542 — DOI: https://doi.org/10.1001/jama.290.4.486